A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk
- 441 Downloads
To measure the effectiveness of a tailored decision aid (DA) designed to help women make informed decisions about genetic testing for breast/ovarian cancer risk.
A total of 145 women were randomized to receive the DA or a control pamphlet at the end of their first genetic counseling consultation. Of these, 120 (82.8%) completed two questionnaires, 1 week and 6 months post-consultation.
While the DA had no effect on informed choice, post-decisional regret or actual genetic testing decision, the trial showed that women who received the DA had higher knowledge levels and felt more informed about genetic testing than women who received the control pamphlet (χ2(2) = 6.82; P = 0.033; χ2(1) = 4.86; P = 0.028 respectively). The DA also helped women who did not have blood drawn at their first consultation to clarify their values with regards to genetic testing (χ2(1) = 5.27; P = 0.022). Women who received the DA were less likely to share the information with other family members than women in the control condition (χ2(1) = 8.78; P = 0.003).
Decision aids are an effective decision-support strategy for women considering genetic testing for breast/ovarian cancer risk, and are most effective before the patient has made a decision, which is generally at the point of having blood drawn.
KeywordsDecision aid Patient education Genetic testing Hereditary breast cancer Hereditary ovarian cancer
- 1.International Breast Cancer Intervention Study Investigators (2002) First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet 360:817–824Google Scholar
- 6.Lodder LN, Frets PG, Trijsburg RW et al (2002) One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery). Breast Cancer Res Treat 73:97–112PubMedCrossRefGoogle Scholar
- 8.National Health and Medical Research Council (1999) Familial aspects of cancer: A guide to clinical practice. National Health and Medical Research Council, Canberra, November 1999Google Scholar
- 16.O’Connor AM (1999) Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications. J Natl Cancer Inst 25:67–80Google Scholar
- 18.Wakefield CE, Meiser B, Homewood J et al (in press) Development and pilot testing of two decision aids for individuals considering genetic testing for cancer risk. J Genet CounsGoogle Scholar
- 19.Australian Cancer Network (1999) Guidelines on familial aspects of cancer. Australian Cancer Network, Sydney, November 1999Google Scholar
- 20.National Breast Cancer Centre (2000) Current best advice about familial aspects of breast/ovarian cancer. NHMRC National Breast Cancer Centre, Sydney, 2000Google Scholar
- 21.Centre for Genetics Education (2007) Centre for Genetics Education. http://www.genetics.com.au/. Cited 19 Jan 2007Google Scholar
- 22.O’Connor AM, Stacey D, Entwistle V et al (2006) Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev 1:1Google Scholar
- 23.Rimer BK, Glassman B (1999) Is there a use for tailored print communications in cancer risk communication? J Natl Cancer Inst 25:140–148Google Scholar
- 34.SPSS Inc. (2005) Statistical Program for the Social Sciences: Release 14.0. SPSS Inc., Chicago, ILGoogle Scholar
- 35.StataCorp (2005) Stata Statistical software: Release 9.0. StataCorp, College Station, TXGoogle Scholar
- 42.O’Neill SM, Peters JA, Vogel VG et al (2006) Referral to cancer genetic counseling: are there stages of readiness? Am J Med Genet C 142:221–231Google Scholar
- 47.Australian Bureau of Statistics (2006) Australian social trends 2006. Australian Bureau of Statistics, CanberraGoogle Scholar